GO:0031782 type 4 melanocortin receptor binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031782 (type 4 melanocortin receptor binding) is a molecular function describing the binding of a ligand to the type 4 melanocortin receptor (MC4R), a class A G-protein-coupled receptor.
• MC4R is a central regulator of energy homeostasis; gain-of-function variants that bias signaling toward Gs-cAMP protect against obesity in humans.
• Ligand binding to MC4R involves specific molecular determinants, including conserved residues in the receptor's orthosteric pocket that dictate affinity and selectivity.
• MC4R signaling is modulated by accessory proteins such as MRAP2, which alters receptor oligomerization and signaling, and by the broader MRAP family.
• Beyond feeding behavior, MC4R-mediated signaling regulates neuronal excitability by inhibiting A-type K+ currents and L-type voltage-gated calcium channels.
• Recent structural and pharmacological advances, including nanobody agonists and ciliary GPCR modulation by GPR45, provide new tools to study MC4R binding and function.
Description
GO:0031782, type 4 melanocortin receptor binding, is a molecular function term that describes the binding of a ligand to the type 4 melanocortin receptor (MC4R). MC4R is a class A G-protein-coupled receptor (GPCR) that plays a central role in the regulation of energy balance and body weight. The binding event is the first step in a signaling cascade that ultimately controls food intake, energy expenditure, and peripheral metabolism. Understanding the molecular details of this binding is critical for drug discovery and for interpreting genetic variants associated with obesity and metabolic disorders. The MC4R receptor is activated by endogenous melanocortin peptides such as alpha-melanocyte-stimulating hormone (alpha-MSH) and inhibited by agouti-related protein (AgRP). The binding of these ligands to MC4R is governed by specific molecular determinants within the receptor's orthosteric pocket. Recent studies have revealed that MC4R signaling is not a simple on/off switch; rather, it is modulated by accessory proteins like MRAP2, which can alter receptor oligomerization and signaling bias. Furthermore, MC4R is expressed in multiple brain regions and in peripheral tissues, where it regulates diverse physiological processes, including neuronal excitability. Research into GO:0031782 has gained momentum due to the discovery of human gain-of-function MC4R variants that protect against obesity by biasing signaling toward the Gs-cAMP pathway. Structural biology efforts, including the development of nanobody agonists, have provided high-resolution insights into the receptor's active state. Additionally, the identification of ciliary GPCRs like GPR45 that modulate G-alpha-s signaling highlights the complexity of melanocortin signaling in the paraventricular hypothalamus. These advances underscore the importance of understanding the molecular basis of type 4 melanocortin receptor binding for both basic biology and therapeutic development.
type 4 melanocortin receptor binding At A Glance
| GO ID | GO:0031782 |
|---|---|
| GO term | type 4 melanocortin receptor binding |
| Ontology | molecular_function |
| Synonym | type 4 melanocortin receptor ligand |
| Definition | Binding to a type 4 melanocortin receptor. |
| Major function | Mediates ligand-receptor interaction that initiates MC4R signaling, regulating energy homeostasis and neuronal excitability. |
| Related receptor | MC4R (melanocortin 4 receptor), a class A GPCR. |
| Key ligands | Alpha-MSH, AgRP, synthetic agonists/antagonists, and nanobody agonists. |
| Modulators | MRAP2 and other MRAP family proteins. |
What Is GO:0031782?
Type 4 melanocortin receptor binding (GO:0031782) is the molecular function of selectively interacting with and binding to a type 4 melanocortin receptor (MC4R). This term encompasses the binding of endogenous peptide ligands, such as alpha-melanocyte-stimulating hormone (alpha-MSH), as well as synthetic agonists or antagonists, to the MC4R receptor. It is a ligand-receptor interaction that initiates downstream signaling events, typically through G-protein activation. The term is used to annotate gene products that act as ligands for MC4R, including peptide hormones and synthetic compounds, and it is distinct from the receptor's own signaling activities.
Why Is type 4 melanocortin receptor binding Important in Cell Biology?
GO:0031782 is critically important because MC4R is a master regulator of energy balance, and its dysfunction is linked to obesity and metabolic disorders. Human genetics have shown that gain-of-function variants in MC4R that bias signaling toward Gs-cAMP are associated with protection against obesity. Conversely, loss-of-function mutations cause monogenic obesity. Understanding the binding event at the molecular level enables the design of therapeutics that can modulate MC4R activity. Moreover, MC4R binding is not limited to metabolic control; it also influences neuronal excitability and pain sensitivity, and it is modulated by accessory proteins that alter receptor pharmacology. Thus, studying this term provides insights into fundamental GPCR biology and offers translational opportunities for treating metabolic and neurological conditions.
• MC4R is a key regulator of food intake and energy expenditure; its binding activity is central to body weight control.
• Gain-of-function MC4R variants that alter ligand binding and signaling bias protect against obesity in humans.
• MC4R-mediated signaling inhibits A-type K+ currents, enhancing sensory neuronal excitability and mechanical pain sensitivity.
• MC4R constitutive activity inhibits L-type voltage-gated calcium channels in neurons, affecting neuronal function.
• MRAP2 modifies MC4R signaling and oligomerization, impacting ligand binding and downstream responses.
• The MRAP family exhibits promiscuity in modulating melanocortin receptors, affecting binding and signaling.
• Nanobody agonists specific for MC4R provide novel tools to probe binding and activation mechanisms.
• GPR45 modulates G-alpha-s at primary cilia of the paraventricular hypothalamus to control food intake, highlighting ciliary GPCR signaling in energy balance.
• Molecular determinants of ligand binding to MC4R have been mapped, aiding drug design.
• Dysregulation of MC4R binding is implicated in obesity, cachexia, and potentially in pain disorders.
Molecular Mechanism of type 4 melanocortin receptor binding
Ligand recognition and orthosteric pocket
In simple terms: The ligand fits into a specific pocket on the receptor, like a key in a lock.
The binding of ligands to MC4R occurs at the orthosteric site, a pocket formed by transmembrane helices. Molecular determinants of ligand binding have been characterized, revealing that specific residues in the receptor, such as those in transmembrane domains 3, 6, and 7, are critical for high-affinity binding of alpha-MSH and other agonists. These interactions involve electrostatic and hydrophobic contacts that stabilize the ligand-receptor complex. The binding specificity is further refined by the ligand's own structure, with key residues in alpha-MSH (e.g., His-Phe-Arg-Trp motif) making essential contacts with the receptor.
Conformational changes and G-protein coupling
In simple terms: Once the ligand binds, the receptor changes shape and activates a G-protein inside the cell.
Ligand binding induces conformational changes in MC4R, particularly in the intracellular loops and the cytoplasmic end of transmembrane helix 6, which facilitates the exchange of GDP for GTP on the Gs alpha subunit. This leads to activation of adenylyl cyclase and increased cAMP production. The efficacy of this coupling can be biased by the nature of the ligand; for example, certain gain-of-function variants of MC4R exhibit biased signaling toward Gs-cAMP, which is associated with protection against obesity. The structural basis of this activation has been illuminated by the development of a nanobody agonist that stabilizes the active state of MC4R.
Modulation by MRAP proteins
In simple terms: Helper proteins can change how the receptor binds ligands and signals.
Melanocortin receptor accessory proteins (MRAPs), particularly MRAP2, interact with MC4R and modulate its signaling and oligomerization state. MRAP2 can alter the receptor's response to ligands, affecting both binding affinity and downstream signaling. The MRAP family exhibits promiscuity, with different MRAPs differentially affecting melanocortin receptor subtypes. This modulation adds an additional layer of regulation to type 4 melanocortin receptor binding, influencing physiological outcomes such as energy homeostasis.
Regulation of neuronal excitability and ion channels
In simple terms: MC4R binding can change how neurons fire by affecting ion channels.
Beyond metabolic control, MC4R signaling regulates neuronal excitability. Activation of MC4R inhibits A-type potassium currents, which enhances sensory neuronal excitability and mechanical pain sensitivity in rats. Additionally, constitutive activity of MC4R inhibits L-type voltage-gated calcium channels in neurons. These effects are downstream of ligand binding and G-protein activation, demonstrating that type 4 melanocortin receptor binding has broad physiological consequences beyond energy balance.
Ciliary localization and GPR45 modulation
In simple terms: Some receptors work in tiny antenna-like structures on cells, and other proteins can influence them there.
MC4R and related GPCRs can localize to primary cilia, where they receive signals. GPR45, a ciliary GPCR, modulates G-alpha-s at primary cilia of the paraventricular hypothalamus to control food intake. This suggests that type 4 melanocortin receptor binding may also occur in specialized ciliary microdomains, where accessory proteins like GPR45 can influence signaling. This emerging area highlights the importance of subcellular localization in regulating MC4R function.
Key Genes Involved in GO:0031782 type 4 melanocortin receptor binding
The following genes and proteins are directly involved in or modulate type 4 melanocortin receptor binding and its downstream effects.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MC4R | Encodes the type 4 melanocortin receptor, a GPCR that binds melanocortin peptides. | Central to energy homeostasis; mutations cause obesity; target for anti-obesity drugs. |
| POMC | Precursor for alpha-MSH, an endogenous agonist of MC4R. | Mutations cause early-onset obesity; source of ligands for binding studies. |
| AGRP | Endogenous antagonist of MC4R. | Regulates feeding; competitive binding to MC4R. |
| MRAP2 | Accessory protein that modulates MC4R signaling and oligomerization. | Alters ligand binding and signaling; linked to obesity. |
| MRAP | Melanocortin receptor accessory protein, modulates receptor trafficking and signaling. | Affects MC4R function; mutations cause rare obesity syndromes. |
| GPR45 | Ciliary GPCR that modulates G-alpha-s signaling in the paraventricular hypothalamus. | Controls food intake; may influence MC4R signaling indirectly. |
| GNAS | Encodes Gs alpha subunit, couples to MC4R upon activation. | Mediates cAMP signaling downstream of MC4R binding. |
| ADCYAP1R1 | Receptor for PACAP, may interact with MC4R signaling. | Potential crosstalk in energy balance. |
| KCNQ2/3 | Potassium channels modulated by MC4R signaling. | Affect neuronal excitability downstream of MC4R. |
| CACNA1C | L-type calcium channel subunit inhibited by MC4R constitutive activity. | Links MC4R to neuronal calcium signaling. |
| KCNA4 | A-type potassium channel subunit inhibited by MC4R signaling. | Mediates effects on sensory neuron excitability. |
| LEPR | Leptin receptor, upstream regulator of POMC and AgRP neurons. | Indirectly affects MC4R ligand availability. |
| PCSK1 | Prohormone convertase 1, processes POMC to alpha-MSH. | Mutations cause obesity; affects ligand production. |
| PCSK2 | Prohormone convertase 2, involved in processing of POMC. | May affect alpha-MSH generation. |
| CART | Cocaine- and amphetamine-regulated transcript, co-expressed with POMC. | Modulates feeding; potential crosstalk with MC4R. |
| BDNF | Brain-derived neurotrophic factor, downstream of MC4R signaling. | Regulates energy balance; mutations cause obesity. |
| SIM1 | Transcription factor in PVH, downstream of MC4R. | Haploinsufficiency causes obesity; mediates MC4R effects. |
| MC3R | Melanocortin 3 receptor, related to MC4R. | Shares ligands; may compensate in MC4R KO. |
How Is type 4 melanocortin receptor binding Regulated?
The binding of ligands to MC4R is regulated at multiple levels. Accessory proteins such as MRAP2 can directly modulate the receptor's binding affinity and signaling efficacy. The MRAP family exhibits promiscuity, with different MRAPs differentially affecting melanocortin receptor subtypes. Additionally, the availability of endogenous ligands is controlled by neuronal circuits in the hypothalamus; leptin and insulin signaling regulate POMC and AgRP expression, thereby influencing the amount of alpha-MSH and AgRP available to bind MC4R. Furthermore, MC4R localization to primary cilia and modulation by ciliary proteins like GPR45 can affect signaling. Post-translational modifications of MC4R, such as phosphorylation and ubiquitination, may also regulate its cell surface expression and binding capacity, although specific details are still emerging.
type 4 melanocortin receptor binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MC4R | Monogenic obesity, protection against obesity (gain-of-function) | Knockout mouse, knock-in of human variants, overexpression in cell lines |
| POMC | Early-onset obesity, adrenal insufficiency | Knockout mouse, iPSC-derived hypothalamic neurons |
| MRAP2 | Obesity, altered MC4R signaling | Knockout mouse, overexpression in cell lines |
| AGRP | Feeding behavior, obesity | Transgenic mouse, knockout |
| GPR45 | Food intake regulation, ciliary signaling | Knockout mouse, ciliary-specific knockout |
Obesity and metabolic disorders
MC4R is the most common monogenic cause of obesity. Loss-of-function mutations in MC4R lead to hyperphagia and severe early-onset obesity. Conversely, gain-of-function variants that bias signaling toward Gs-cAMP are associated with protection against obesity. These findings highlight the importance of type 4 melanocortin receptor binding in energy homeostasis. Therapeutic strategies aimed at enhancing MC4R binding or signaling are being explored for obesity treatment.
Pain and sensory neuron excitability
MC4R-mediated inhibition of A-type potassium currents enhances sensory neuronal excitability and mechanical pain sensitivity in rats. This suggests that MC4R binding and signaling may contribute to pain perception. Targeting MC4R could therefore have implications for pain management, although further research is needed to translate these findings to humans.
Neuronal function and calcium signaling
Constitutive activity of MC4R inhibits L-type voltage-gated calcium channels in neurons. This regulation of calcium channels may affect neuronal plasticity, neurotransmitter release, and other calcium-dependent processes. Dysregulation of MC4R signaling could thus impact neurological functions beyond energy balance.
Ciliary signaling and hypothalamic control of food intake
GPR45, a ciliary GPCR, modulates G-alpha-s at primary cilia of the paraventricular hypothalamus to control food intake. This suggests that ciliary signaling pathways, potentially involving MC4R, play a role in hypothalamic control of energy balance. Defects in ciliary signaling may contribute to obesity and related metabolic disorders.
From type 4 melanocortin receptor binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene affect MC4R ligand binding? | Overexpression of candidate gene in MC4R-expressing cells followed by radioligand binding assay. |
| What is the effect of a specific MC4R mutation on binding affinity? | Point mutation knock-in in cell lines or mice, followed by binding assays. |
| How does MRAP2 modulate MC4R binding? | Knockout of MRAP2 in cell lines or mice, with binding and signaling assays. |
| What is the role of MC4R in energy homeostasis in vivo? | MC4R knockout mouse, conditional knockout in specific brain regions. |
| Can a nanobody agonist activate MC4R in vivo? | Knock-in of nanobody target or administration of nanobody in mouse models. |
| Does GPR45 interact with MC4R in cilia? | Knockout of GPR45 in mice, ciliary localization studies, co-immunoprecipitation. |
How to Study the type 4 melanocortin receptor binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding assay | Binding affinity and receptor density | Characterizing ligand-receptor interactions |
| cAMP accumulation assay | Gs-mediated signaling | Assessing agonist efficacy and biased signaling |
| Surface plasmon resonance | Real-time binding kinetics | Measuring association/dissociation rates |
| Cryo-EM | High-resolution structure of receptor-ligand complex | Understanding conformational changes upon binding |
| Immunoprecipitation | Protein-protein interactions | Identifying accessory proteins like MRAP2 |
| Knockout mouse | Physiological role of gene | Studying energy homeostasis and neuronal function |
| Patch-clamp electrophysiology | Ion channel activity | Measuring effects on neuronal excitability |
Radioligand binding assays
Radioligand binding assays are the gold standard for measuring type 4 melanocortin receptor binding. Using radiolabeled alpha-MSH or synthetic agonists, researchers can determine binding affinity (Kd) and receptor density (Bmax) in membrane preparations from cells or tissues expressing MC4R. Competition binding assays with unlabeled ligands can reveal the affinity of novel compounds. These assays are essential for characterizing the molecular determinants of ligand binding and for screening drug candidates.
Cell-based signaling assays
Cell-based assays measure downstream signaling events following MC4R activation, such as cAMP accumulation, calcium mobilization, or reporter gene expression. These assays can be used to assess the functional consequences of ligand binding and to detect biased signaling. For example, gain-of-function MC4R variants can be tested for their ability to stimulate cAMP in response to alpha-MSH. Such assays are high-throughput and suitable for drug discovery.
Structural biology and biophysical techniques
Structural biology methods, including X-ray crystallography and cryo-electron microscopy, have provided insights into the active state of MC4R bound to agonists or nanobodies. Biophysical techniques such as surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) can measure binding kinetics and thermodynamics in real time. These approaches reveal the conformational changes and molecular interactions that underlie type 4 melanocortin receptor binding.
Genetic and pharmacological manipulation in animal models
Animal models, particularly mice, are used to study the physiological role of MC4R binding. Knockout, knock-in, and transgenic models allow researchers to manipulate MC4R expression or function and assess effects on food intake, body weight, and neuronal activity. Pharmacological administration of agonists or antagonists can complement genetic approaches. These models are crucial for translating molecular findings to whole-organism physiology.
How CRISPR Can Be Used to Study GO:0031782 type 4 melanocortin receptor binding
Knockout
CRISPR-Cas9 knockout of MC4R or its modulators (e.g., MRAP2) in cell lines or animal models can abolish type 4 melanocortin receptor binding and signaling. This approach is used to study the physiological consequences of loss of function, such as obesity and altered neuronal excitability. Knockout models also serve as negative controls in binding assays.
Point Mutation
CRISPR-mediated point mutations can introduce specific amino acid substitutions in MC4R that are found in human patients or that are predicted to affect ligand binding. These models allow researchers to dissect the molecular determinants of binding affinity and signaling bias. For example, mutations in the orthosteric pocket can be tested for their impact on alpha-MSH binding.
Knock-in
Knock-in of human MC4R variants (e.g., gain-of-function alleles) into mouse models or cell lines enables the study of their effects on energy balance and signaling in a physiological context. Tagged knock-in (e.g., GFP or HA tag) allows visualization and purification of the receptor for biochemical studies. Knock-in models are valuable for translational research.
Overexpression
Overexpression of MC4R or its ligands (e.g., alpha-MSH) in cell lines or transgenic animals can enhance binding and signaling, facilitating biochemical and pharmacological studies. Overexpression systems are often used for high-throughput screening of compounds that modulate type 4 melanocortin receptor binding. However, careful controls are needed to avoid artifacts from supraphysiological expression levels.
How EDITGENE Supports type 4 melanocortin receptor binding Research
Researchers studying type 4 melanocortin receptor binding-related genes often need to determine whether a candidate gene is causally involved in ligand binding, receptor signaling, or downstream physiology. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell and animal models, enabling rigorous investigation of GO:0031782 and its associated pathways.
Contact EDITGENE today to design your custom CRISPR model for type 4 melanocortin receptor binding research.
Frequently Asked Questions About type 4 melanocortin receptor binding
What is GO:0031782?
GO:0031782 is the Gene Ontology molecular function term for type 4 melanocortin receptor binding, which describes the binding of a ligand to the MC4R receptor.
What genes are involved in type 4 melanocortin receptor binding?
Key genes include MC4R (the receptor), POMC (ligand precursor), AGRP (antagonist), MRAP2 (modulator), and GNAS (G-protein subunit).
What is the function of MC4R?
MC4R is a G-protein-coupled receptor that regulates food intake and energy expenditure; its binding to ligands initiates signaling that controls body weight.
How does MC4R binding affect obesity?
Gain-of-function variants that enhance MC4R binding and signaling protect against obesity, while loss-of-function mutations cause severe obesity.
What are the endogenous ligands for MC4R?
Alpha-melanocyte-stimulating hormone (alpha-MSH) is an agonist, and agouti-related protein (AgRP) is an antagonist.
How is MC4R signaling regulated?
MC4R signaling is modulated by accessory proteins like MRAP2, by ligand availability, and by ciliary localization involving proteins like GPR45.
What methods are used to study type 4 melanocortin receptor binding?
Common methods include radioligand binding assays, cAMP signaling assays, surface plasmon resonance, and structural biology techniques like cryo-EM.
Can CRISPR be used to study MC4R binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect MC4R binding and signaling.
What diseases are associated with MC4R mutations?
MC4R mutations are linked to monogenic obesity, and MC4R signaling may also influence pain sensitivity and neuronal function.
What services does EDITGENE offer for MC4R research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, library screening, and bioinformatics analysis for MC4R and related genes.
Conclusion
Type 4 melanocortin receptor binding (GO:0031782) is a fundamental molecular function that governs energy homeostasis, neuronal excitability, and metabolic health. The interaction between MC4R and its ligands is finely tuned by molecular determinants, accessory proteins, and cellular context. Dysregulation of this binding event is implicated in obesity and potentially in pain and neurological disorders. Advances in structural biology, CRISPR genome editing, and pharmacological tools continue to illuminate the mechanisms and therapeutic potential of targeting MC4R. EDITGENE's comprehensive CRISPR services empower researchers to create precise models for studying type 4 melanocortin receptor binding and to accelerate drug discovery in this critical field.
References
- 1. Xun Y et al.. 2025. GPR45 modulates Gα(s) at primary cilia of the paraventricular hypothalamus to control food intake.. Science 388(6751):eadp3989 PMID: 40472089
- 2. Lotta LA et al.. 2019. Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity.. Cell 177(3):597-607.e9 PMID: 31002796
- 3. Zhang Y et al.. 2019. Melanocortin type 4 receptor-mediated inhibition of A-type K(+) current enhances sensory neuronal excitability and mechanical pain sensitivity in rats.. J Biol Chem 294(14):5496-5507 PMID: 30745360
- 4. Sohail I et al.. 2025. MRAP2 modifies the signaling and oligomerization state of the melanocortin-4 receptor.. Nat Commun 16(1):8324 PMID: 40998819
- 5. Agosti F et al.. 2017. Melanocortin 4 receptor constitutive activity inhibits L-type voltage-gated calcium channels in neurons.. Neuroscience 346:102-112 PMID: 28093215
- 6. Clark AJ et al.. 2017. Promiscuity among the MRAPs.. J Mol Endocrinol 58(3):F1-F4 PMID: 28213370
- 7. Fontaine T et al.. 2024. Structure elucidation of a human melanocortin-4 receptor specific orthosteric nanobody agonist.. Nat Commun 15(1):7029 PMID: 39353917
- 8. Yang YK et al.. 2000. Molecular determinants of ligand binding to the human melanocortin-4 receptor.. Biochemistry 39(48):14900-11 PMID: 11101306
